Navigation Links
Cancer drug shows promise for treating a wide range of inflammatory diseases
Date:6/30/2010

Those looking for a new treatment for a range of inflammatory diseases like arthritis, multiple sclerosis, inflammatory bowel disease, and lupus may need to look no further than a drug already available for treating cancer. In a research report published in the July 2010 print issue of the Journal of Leukocyte Biology (http://www.jleukbio.org), Japanese scientists use mice to show that bortezomib, currently used to treat cancers that affect white blood cells, induces cell death only in harmful (active and proliferating) T cells, leaving the rest unharmed. If the results prove true in humans, it offers hope that this drugs or others similar to it might be used to treat inflammatory diseases without the side effects of current drugs that affect all T cells equally.

"Unfortunately, there are a lot of people who are suffering from autoimmune and inflammatory disease," said Koichi Yanaba, M.D., Ph.D., a scientist from the Department of Dermatology at Nagasaki University Graduate School of Biomedical Sciences who was involved in the research. "We believe that this new-type remedy for autoimmune and inflammatory disease could successfully treat them in the near future."

To make this discovery, scientists used two groups of micethe first treated with bortezomib and the second with saline. Researchers induced contact hypersensitivity reaction with oxazolone, a chemical allergen used for immunological experiments and found that bortezomib significantly inhibited the contact hypersensitivity responses. Results strongly suggest that bortezomib treatment enhanced T cell death by inhibiting NF-kappa B activation, which plays a key role in regulating the immune response to infection. This in turn led to the suppression of inflammatory responses in immune cells by reducing interferon-gamma production.

"Any time you learn that a drug already on the market has the potential to be used for more illnesses than originally thought, it's a hopeful discovery," said Luis J. Montaner, D.V.M., M.Sc., D.Phil., Editor-in-Chief of the Journal of Leukocyte Biology, "Even if this drug is not quite as successful in humans, it raises the possibility that a similar compound could be created which would be more successful."


'/>"/>

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
Source:Eurekalert

Related medicine news :

1. A key mechanism links virgin olive oil to protection against breast cancer
2. Interventions to promote repeat breast cancer screening with mammography
3. Smoking-related colorectal cancer in older women is associated with molecularly-defined DNA changes
4. Researchers suggest new paradigm for breast cancer screening
5. Smoking May Boost Risk of Certain Colon Cancers
6. Study shows how dietary supplement may block cancer cells
7. Statins May Lower Rates of Prostate Cancer Recurrence
8. Fewer than half of breast cancer patients adhere to hormonal therapy regimen, study finds
9. Bursting bubbles with sound offers new treatments for cancer
10. More than a million parents with minor children are cancer survivors
11. A New Approach to Quantifying Risk of Developing Lung Cancer is published in Academic Radiology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... ... With ProGlass Prism users now have the ability to simulate prism distortions ... rotation, distortion, edge softness, edge blur, chromatic aberration, individual glass position offset, anchor point, ... users are given the tools and effects to generate a fractal prismatic displacement ...
(Date:2/24/2017)... ... ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced that he ... of the Management Committee when IFN was originally formed in 2002 where he was ... development of the business plan. He became the first paid employee of IFN ...
(Date:2/24/2017)... ... February 24, 2017 , ... Castle Farms, the celebrated ... Giveaway, with the winning couple announced on Feb. 14, 2017, on Facebook. The ... local vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch of Spring ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in Miami Beach to host its Swirl: Miami Wine Tasting Event on March ...
(Date:2/23/2017)... ... February 23, 2017 , ... Hamlin Dental Group and ... they are sponsoring a raffle. Throughout the month of February, patients who visit Hamlin ... gift card for a dinner for two at the Cheesecake Factory. , Tickets ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 24, 2017 Research and Markets has announced the ... report to their offering. ... The latest research Hemophilia Drugs Price Analysis and Strategies - 2016, ... The research answers the following questions: What ... are they positioned in the Global Hemophilia market? What ...
(Date:2/24/2017)... Feb. 24, 2017 Juan Monteverde , ... PC , a boutique securities firm headquartered at the ... , announces that a class action lawsuit has ...  against Inotek Pharmaceuticals Corporation (NASDAQ:  ITEK)("Inotek" or ... securities between July 23, 2015 and December 30, 2016, inclusive ...
(Date:2/24/2017)... Australia , Feb. 23, 2017  Directors from Pharma To ... two companies have joined forces, resulting in the founding of Pharma ... Pharma To Market are pleased to announce their expansion ... office in Singapore . The company are delighted ... as Co-Director of the Singapore based entity. ...
Breaking Medicine Technology: